文献速递冠心病外科

慢性阻塞性肺疾病对左主干冠状动脉疾病血运重建后预后的影响:EXCEL试验分析

Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

基于EXCEL试验,评估COPD对左主干冠状动脉疾病患者接受PCI或CABG后临床结局的影响。倾向性评分匹配后,COPD患者3年死亡、心肌梗死或卒中复合终点发生率显著更高,但PCI与CABG的相对风险在COPD与非COPD患者中无显著交互作用。

要点

  • COPD是左主干血运重建后不良预后的独立关联因素。
  • COPD患者3年复合终点、死亡和心肌梗死率均显著高于无COPD者。
  • PCI与CABG的相对风险在COPD与非COPD患者中无显著差异。

核心结论

  • 在EXCEL试验中,COPD与左主干冠状动脉疾病血运重建后不良预后独立相关。
  • PCI与CABG在30天和3年的相对风险在COPD与非COPD患者中保持一致。

研究设计与样本

  • EXCEL试验的事后分析,比较PCI(依维莫司洗脱支架)与CABG治疗左主干冠状动脉疾病且SYNTAX评分低或中等的患者。
  • 1905例随机患者中1901例(99.8%)有COPD状态,148例(7.8%)有COPD。
  • 倾向性评分匹配后纳入135例COPD患者和675例无COPD患者。

主要发现

  • COPD患者3年死亡、心肌梗死或卒中复合终点发生率为31.7% vs 14.5%(P < 0.0001)。
  • COPD患者3年死亡率为17.1% vs 7.5%(P = 0.0005),心肌梗死率为18.3% vs 7.3%(P < 0.0001)。
  • 卒中发生率无显著差异(3.3% vs 2.9%,P = 0.84)。
  • 30天PCI vs CABG复合终点HR在COPD患者为0.39(95%CI 0.12-1.21),无COPD患者为0.55(95%CI 0.29-1.06),Pinteraction = 0.61。
  • 3年PCI vs CABG复合终点HR在COPD患者为0.85(95%CI 0.46-1.56),无COPD患者为1.28(95%CI 0.84-1.94),Pinteraction = 0.27。

临床怎么用

  • 对左主干冠状动脉疾病合并COPD的患者,血运重建决策时需认识到COPD与较差预后相关。
  • PCI与CABG的相对风险在COPD与非COPD患者中无显著差异,支持两种策略均可考虑。

局限性

  • COPD诊断基于病史,未报告肺功能检查确认。
  • 为事后分析,COPD亚组样本量较小(匹配后135例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Percutaneous coronary intervention (PCI) is often favoured over coronary artery bypass grafting (CABG) surgery for revascularization in patients with chronic obstructive pulmonary disease (COPD). We studied whether COPD affected clinical outcomes according to revascularization in the Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial, in which PCI with everolimus-eluting stents was non-inferior to CABG for the treatment of patients with left main coronary artery disease and low or intermediate SYNTAX scores. METHODS: Patients with a history of COPD were propensity score matched to those without COPD. Outcomes at 30 days and 3 years in both groups were compared in patients randomized to PCI versus CABG. RESULTS: COPD status was available for 1901 of 1905 randomized patients (99.8%), 148 of whom had COPD (7.8%). Propensity score matching yielded 135 patients with COPD and 675 patients without COPD. Patients with COPD had higher 3-year rates of the primary composite end point of death, myocardial infarction or stroke (31.7% vs 14.5%, P < 0.0001), death (17.1% vs 7.5%, P = 0.0005) and myocardial infarction (18.3% vs 7.3%, P < 0.0001), but not stroke (3.3% vs 2.9%, P = 0.84). There were no statistically significant interactions in the relative risks of PCI versus CABG for the primary composite end point in patients with and without COPD at 30 days [hazard ratio (HR) 0.39, 95% confidence interval (CI) 0.12-1.21 vs HR 0.55, 95% CI 0.29-1.06; Pinteraction = 0.61] or at 3 years (HR 0.85, 95% CI 0.46-1.56 vs HR 1.28, 95% CI 0.84-1.94; Pinteraction = 0.27). CONCLUSIONS: In the EXCEL trial, COPD was independently associated with poor prognosis after left main coronary artery disease revascularization. The relative risks of PCI versus CABG at 30 days and 3 years were consistent in patients with and without COPD. CLINICAL TRIAL REGISTRATION NUMBER: http://www.clinicaltrials.gov; NCT01205776.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Huang X, Redfors B, Chen S, et al. Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial. Eur J Cardiothorac Surg. 2019. PMID: 30596978. doi:10.1093/ejcts/ezy438

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。